Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ’s Fasenra study confirms robust efficacy in eosinophilic asthma

pharmatimesAugust 11, 2020

Tag: FASENRA , eosinophilic asthma , AstraZeneca

PharmaSources Customer Service